患癌与未患癌女性体能功能下降的长期轨迹
这项前瞻性队列研究纳入9203例老年女性癌症患者(乳腺癌5989例、结直肠癌1352例、子宫内膜癌960例、肺癌902例)并按年龄和入组年份匹配45358名无癌对照,随访至2020年12月。结果显示癌症诊断后体能功能较对照加速下降,局部病患者诊断前下降与对照相似,区域病患者及接受全身治疗者短期下降最明显,诊断5年后幸存者体能功能仍显著低于年龄匹配对照。
要点
- 癌症幸存者诊断后体能功能较无癌对照加速下降,诊断5年后仍低于年龄匹配对照。
- 区域病患者诊断后1年内下降最明显,如区域性乳腺癌每年下降5.3分,局部性为2.8分。
- 接受全身治疗者短期下降更明显,如局部子宫内膜癌接受化疗者每年下降7.9分。
核心结论
- 在这项前瞻性队列研究中,癌症幸存者诊断后体能功能加速下降,且即使多年后仍低于年龄匹配对照。
- 癌症患者可能从支持性干预中获益以保持体能功能。
研究设计与样本
- 前瞻性队列研究,1993至1998年入组,随访至2020年12月。
- 女性健康倡议(Women's Health Initiative)队列中9203例新发癌症(乳腺癌5989例、结直肠癌1352例、子宫内膜癌960例、肺癌902例),按年龄、入组年份和研究臂匹配最多5名对照,共45358名对照。
- 癌症诊断部位、分期和治疗通过Medicare和病历获取;体能功能采用RAND Short Form 36(RAND-36)量表自报,范围0-100分,分数越高体能功能越好。
- 采用线性混合效应模型估计诊断时及诊断后1年斜率变化的体能功能轨迹。
- 癌症组诊断时平均(SD)年龄为73.0(7.6)岁。
主要发现
- 诊断前,局部癌幸存者体能功能下降与对照相似;诊断后,幸存者较对照加速下降,对照评分每年下降1至2分。
- 诊断后1年内短期下降在区域病患者中最严重,如区域性乳腺癌每年下降5.3分(95%CI -6.4至-4.3),局部性乳腺癌每年下降2.8分(95%CI -3.4至-2.3)。
- 接受全身治疗者短期下降更明显,如局部子宫内膜癌接受任何化疗者每年下降7.9分(95%CI -12.2至-3.6),仅放疗者每年下降3.1分(95%CI -6.0至-0.3),两者均未接受者每年下降2.6分(95%CI -4.2至-1.0)。
- 诊断后后期体能功能下降速率放缓,如区域性结直肠癌诊断后1年内每年下降4.3分(95%CI -5.9至-2.6),此后十年每年下降1.4分(95%CI -1.7至-1.0)。
- 诊断5年后,幸存者估计体能功能显著低于年龄匹配对照。
临床怎么用
- 原文结论指出癌症患者可能从支持性干预中获益以保持体能功能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Patients with cancer experience acute declines in physical function, hypothesized to reflect accelerated aging driven by cancer-related symptoms and effects of cancer therapies. No study has examined long-term trajectories of physical function by cancer site, stage, or treatment compared with cancer-free controls. OBJECTIVE: Examine trajectories of physical function a decade before and after cancer diagnosis among older survivors and cancer-free controls. DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study enrolled patients from 1993 to 1998 and followed up until December 2020. The Women's Health Initiative, a diverse cohort of postmenopausal women, included 9203 incident cancers (5989 breast, 1352 colorectal, 960 endometrial, and 902 lung) matched to up to 5 controls (n = 45 358) on age/year of enrollment and study arm. EXPOSURES: Cancer diagnosis (site, stage, and treatment) via Medicare and medical records. MAIN OUTCOMES AND MEASURES: Trajectories of self-reported physical function (RAND Short Form 36 [RAND-36] scale; range: 0-100, higher scores indicate superior physical function) estimated from linear mixed effects models with slope changes at diagnosis and 1-year after diagnosis. RESULTS: This study included 9203 women with cancer and 45 358 matched controls. For the women with cancer, the mean (SD) age at diagnosis was 73.0 (7.6) years. Prediagnosis, physical function declines of survivors with local cancers were similar to controls; after diagnosis, survivors experienced accelerated declines relative to controls, whose scores declined 1 to 2 points per year. Short-term declines in the year following diagnosis were most severe in women with regional disease (eg, -5.3 [95% CI, -6.4 to -4.3] points per year in regional vs -2.8 [95% CI, -3.4 to -2.3] for local breast cancer) or who received systemic therapy (eg, for local endometrial cancer, -7.9 [95% CI, -12.2 to -3.6] points per year with any chemotherapy; -3.1 [95% CI, -6.0 to -0.3] with radiation therapy alone; and -2.6 [95% CI, -4.2 to -1.0] with neither, respectively). While rates of physical function decline slowed in the later postdiagnosis period (eg, women with regional colorectal cancer declined -4.3 [95% CI, -5.9 to -2.6] points per year in the year following diagnosis vs -1.4 [95% CI, -1.7 to -1.0] points per year in the decade thereafter), survivors had estimated physical function significantly below that of age-matched controls 5 years after diagnosis. CONCLUSIONS AND RELEVANCE: In this prospective cohort study, survivors of cancer experienced accelerated declines in physical function after diagnosis, and physical function remained below that of age-matched controls even years later. Patients with cancer may benefit from supportive interventions to preserve physical functioning.
引用
- Cespedes Feliciano EM, Vasan S, Luo J, et al. Long-term Trajectories of Physical Function Decline in Women With and Without Cancer. JAMA Oncol. 2023. PMID: 36656572. doi:10.1001/jamaoncol.2022.6881
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。